FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to oxazolidinone derivatives of formula
(I),
wherein R1 and R'1 independently mean hydrogen or fluorine; R2 means -OR7, a monophosphate or a phosphate metal salt; R7 means hydrogen or an acylated amino acid group, wherein amino acid is alanine, glycine, proline, β-alanine or valine; Het means oxadiazolyl; R3 means C1-4alkyl. Besides, the invention refers to a pharmaceutical composition, using it and methods for producing compounds of formula (I).
EFFECT: oxazolidinone derivatives of formula (I) possessing antibacterial activity.
28 cl, 4 tbl, 73 ex
Title | Year | Author | Number |
---|---|---|---|
NOVEL OXAZOLIDINONE DERIVATIVES | 2004 |
|
RU2414469C2 |
NOVEL OXADIAZOLE-BASED COMPOUNDS FOR CONTROLLING PHYTOPATHOGENIC FUNGI OR PREVENTING DAMAGE BY THEM | 2020 |
|
RU2818085C2 |
USE OF 1H-PYRAZOLO[4,3-B]PYRIDINES AS PDE1 INHIBITORS | 2017 |
|
RU2759380C2 |
PHENICOL ANTIBACTERIAL AGENTS | 2013 |
|
RU2593204C2 |
PIPERIDINYLPYRAZOLOPYRIMIDINONES AND USE THEREOF | 2015 |
|
RU2713937C2 |
HETEROCYCLIC COMPOUND AS PROTEIN KINASE INHIBITOR | 2018 |
|
RU2783723C2 |
PIPERIDINE DERIVATIVES | 2011 |
|
RU2554353C2 |
BICYCLIC TETRAHYDROTHIAZEPINE DERIVATIVES USEFUL FOR TREATING NEOPLASTIC AND/OR INFECTIOUS DISEASES | 2016 |
|
RU2730524C2 |
AZADECALINS CONDENSED WITH HETEROARYLKETONES - GLUCOCORTICOID RECEPTOR MODULATORS | 2013 |
|
RU2639867C2 |
SUBSTITUTED PHENOXY-ACETIC ACIDS, WITH MODULATING EFFECT ON CRTh2 RECEPTORS | 2004 |
|
RU2372330C2 |
Authors
Dates
2015-08-10—Published
2004-12-17—Filed